These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vivo and in vitro effects of beta-naphthoflavone on cytochrome P-450-dependent testosterone hydroxylase activities in liver microsomes.
    Author: Shiverick KT.
    Journal: Drug Metab Dispos; 1981; 9(6):545-50. PubMed ID: 6120814.
    Abstract:
    Hepatic microsomes from beta-naphthoflavone-treated adult male rats exhibit a 60-86% loss of testosterone 7 alpha-, 16 alpha-, and 6 beta-hydroxylase activities compared to those of untreated animals. Studies were conducted to determine if the loss of mono-oxygenase activities reflected the presence of beta-naphthoflavone in microsomes from treated animals or, rather, involved a change in the constitutive forms of cytochrome P-450 involved in testosterone hydroxylation. In vitro preincubation of microsomes from untreated animals with NADPH and beta-naphthoflavone resulted in a selective 30-40% loss of 16 alpha- and 6 beta-hydroxylase activities, results which suggest that a metabolite of beta-naphthoflavone may selectively inhibit testosterone hydroxylase activities. Hepatic microsomes from untreated sexually immature and adult rats and from beta-naphthoflavone-treated adult male rats were solubilized and each resolved into three or four cytochrome P-450 fractions by ion-exchange chromatography. The various cytochrome fractions were distinguished by their CO-difference spectra and reconstituted catalytic activity. Cytochrome P-450 fractions from beta-naphthoflavone-treated adult male rats exhibited only 10% of the 16 alpha- and 2 beta-hydroxylase activities of the analogous fractions from untreated adult male microsomes. The catalytic activity of the fractions from beta-naphthoflavone-treated adults was similar to that of cytochrome P-450 from sexually immature male rats. These data indicate that in vivo administration of beta-naphthoflavone results in a selective loss of androgen-dependent cytochrome P-450 testosterone hydroxylase activity.
    [Abstract] [Full Text] [Related] [New Search]